Literature DB >> 6280896

Dexamethasone suppression of adrenocortical function.

A M Sharp, D J Handelsman, R M Ristuccia, J R Turtle.   

Abstract

To investigate the potency of dexamethasone in suppressing adrenocortical function, we gave various evening doses to laboratory staff members. Plasma corticotropin, cortisol, and dehydroepiandrosterone sulfate concentrations were measured the following day, to quantitate the degree of suppression after both short- and long-term treatments. We found that the minimum amount for effective suppression was 1 mg for a single evening dose, 0.5 mg per day for a long-term evening dose. On these regimens plasma corticotropin and cortisol were consistently suppressed, but plasma dehydroepiandrosterone sulfate was suppressed only with long-term treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280896

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Influence of the time of administration of dexamethasone 0.25 mg on cortisol secretion in normal humans.

Authors:  P Schulz; C Costa; J Widmer; P Dick
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effects of etomidate combined with dexmedetomidine on adrenocortical function in elderly patients: a double-blind randomized controlled trial.

Authors:  Fangjun Wang; Zheng Yang; Sisi Zeng; Luyue Gao; Jiabei Li; Na Wang
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

3.  A large volume spacer significantly reduces the effect of inhaled steroids on bone formation.

Authors:  K Meeran; J M Burrin; K A Noonan; C P Price; P W Ind
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.